INDUCTION OF IL-12 USING IMMUNOTHERAPY

• 收藏
• 分享

专利权人:

Ltd.;Immunovative Therapies

发明人:

Har-Noy, Michael

申请号：

AU2017204058

公开号：

AU2017204058A1

申请日:

2017.06.15

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

#$%^&*AU2017204058A120170713.pdf#####The present invention provides for a composition for increasing the level of IL-12, said composition comprising activated allogeneic T cells, or essentially consisting of: a foreign antigen； at least one Th1 cytokine； and a DC maturation molecule. The invention also provides for method of increasing plasma levels of IL-12 in a patient comprising administering a composition comprising allogeneic cells wherein at least a portion of the cells are activated T-cells.1/1 IL12 level in the blood of patient #11 during the CFB protocol .0,0 . -- -150,000 1(O ] ---- - --------500,000 - ' - - - -- - -2fQOD/I.protocol..VFIGURE 1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/